Trial intelligence / Profile preview

Bioavailability of Ibuprofen ODT vs Tablets in Healthy Volunteers

NCT03180879Phase 1Completed

Sponsor
Reckitt
Start
Apr 2017
Primary completion
Jun 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of ibuprofen in pain, fever and inflammation (6 arms), sponsored by Reckitt. Primary endpoints: Area Under the Plasma Concentration Curve from Administration to Last Quantifiable Concentration and Maximum Observed Plasma Concentration. Started Apr 2017; status: completed.

02

Drugs

ibuprofen
03

Conditions

painfeverinflammation

Beyond the preview

Go deeper on NCT03180879.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03180879.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call